{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T17:15:37Z","timestamp":1782321337974,"version":"3.54.5"},"reference-count":18,"publisher":"Elsevier BV","issue":"35","license":[{"start":{"date-parts":[[2016,7,1]],"date-time":"2016-07-01T00:00:00Z","timestamp":1467331200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,7,18]],"date-time":"2016-07-18T00:00:00Z","timestamp":1468800000000},"content-version":"vor","delay-in-days":17,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2016,7]]},"DOI":"10.1016\/j.vaccine.2016.06.073","type":"journal-article","created":{"date-parts":[[2016,7,7]],"date-time":"2016-07-07T05:33:42Z","timestamp":1467869622000},"page":"4140-4144","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Protection induced by a commercial bivalent vaccine against Foot-and-Mouth Disease 2010 field virus from Ecuador"],"prefix":"10.1016","volume":"34","author":[{"given":"Hernando","family":"Duque","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose","family":"Naranjo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Consuelo","family":"Carrillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Burbano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"Vargas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Pauszek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian","family":"Olesen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel J.","family":"Sanchez-Vazquez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ottorino","family":"Cosivi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rossana M.","family":"Allende","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2016.06.073_b0005","series-title":"Organizaci\u00f3n Panamericana de la Salud. Reuni\u00f3n Interamericana sobre el control de la fiebre aftosa y otras zoonosis","first-page":"62","article-title":"Estudios sobre vacunas de virus vivo contra fiebre aftosa","author":"Palacios","year":"1968"},{"key":"10.1016\/j.vaccine.2016.06.073_b0010","doi-asserted-by":"crossref","first-page":"20120381","DOI":"10.1098\/rstb.2012.0381","article-title":"Elimination of foot-and-mouth disease in South America: lessons and challenges","volume":"368","author":"Naranjo","year":"2013","journal-title":"Philos Trans Roy Soc B"},{"key":"10.1016\/j.vaccine.2016.06.073_b0015","unstructured":"FAO. Nota T\u00e9cnica: Interpretaci\u00f3n de los resultados laboratoriales de caracterizaci\u00f3n filogen\u00e9tica y antig\u00e9nica de cepas de virus de fiebre aftosa y opciones estrat\u00e9gicas para el programa de erradicaci\u00f3n de Ecuador. Proyecto GCP\/RLA\/178\/SPA y GTFS\/RLA\/172\/ITA; 2011, 27 p."},{"key":"10.1016\/j.vaccine.2016.06.073_b0020","doi-asserted-by":"crossref","first-page":"8230","DOI":"10.1016\/j.vaccine.2011.08.120","article-title":"Characterization of foot-and-mouth disease virus from outbreaks in Ecuador during 2009\u20132010 and cross-protection studies with the vaccine strain in use in the region","volume":"29","author":"Maradei","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.06.073_b0025","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1177\/104063879200400304","article-title":"Foot-and-mouth disease virus typing by complement fixation and enzyme-linked-immunosorbent assay using monovalent and polyvalent antisera","volume":"4","author":"Alonso","year":"1992","journal-title":"J Vet Diagn Invest"},{"key":"10.1016\/j.vaccine.2016.06.073_b0030","series-title":"Proceedings of the international symposium on foot-and-mouth disease: variants and immunity, 1967, Lyon, Karger Basel, Switzerland","first-page":"1","article-title":"Variants and immunity: definitions for serological investigation","author":"Brooksby","year":"1968"},{"key":"10.1016\/j.vaccine.2016.06.073_b0035","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.virusres.2006.09.006","article-title":"Phylogenetic analysis of foot-and-mouth disease virus type O re-emerging in free areas of South America","volume":"124","author":"Malirat","year":"2007","journal-title":"Virus Res"},{"issue":"10","key":"10.1016\/j.vaccine.2016.06.073_b0040","doi-asserted-by":"crossref","first-page":"6487","DOI":"10.1128\/JVI.79.10.6487-6504.2005","article-title":"2005 Comparative genomics of foot-and-mouth disease virus","volume":"79","author":"Carrillo","year":"2005","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2016.06.073_b0045","doi-asserted-by":"crossref","first-page":"2725","DOI":"10.1093\/molbev\/mst197","article-title":"MEGA6: molecular evolutionary genetics analysis version 6.0","volume":"30","author":"Koichiro","year":"2013","journal-title":"Mol Biol Evol"},{"key":"10.1016\/j.vaccine.2016.06.073_b0050","series-title":"Manual of diagnostic tests and vaccines for terrestrial animals","article-title":"Foot and mouth disease","author":"World Organization for Animal Health","year":"2012"},{"issue":"22","key":"10.1016\/j.vaccine.2016.06.073_b0055","first-page":"21","article-title":"Microtiter neutralization test for the study of foot-and-mouth disease antibodies: brief report","volume":"21","author":"Ferreira","year":"1976","journal-title":"Bol Cent Panam Fiebre Aftosa"},{"key":"10.1016\/j.vaccine.2016.06.073_b0060","series-title":"Manual of diagnostic tests and vaccines for terrestrial animals","article-title":"Foot and mouth disease","author":"World Organization for Animal Health","year":"2008"},{"key":"10.1016\/j.vaccine.2016.06.073_b0065","series-title":"Foot-and-mouth disease: control strategies","first-page":"331","article-title":"South American standards for foot and mouth disease vaccine quality","author":"Allende","year":"2003"},{"key":"10.1016\/j.vaccine.2016.06.073_b0070","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1016\/0264-410X(93)90171-S","article-title":"Potency control of foot-and-mouth disease vaccine in cattle. Comparison of the 50% protective dose and the protection against generalization","volume":"11","author":"Vianna Filho","year":"1993","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.06.073_b0075","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/j.vaccine.2012.12.011","article-title":"The field effectiveness of routine and emergency vaccination with an inactivated vaccine against foot and mouth disease","volume":"31","author":"Elnekave","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.06.073_b0080","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/j.vaccine.2008.11.026","article-title":"Some guidelines for determining foot-and-mouth disease vaccine strain matching by serology","volume":"27","author":"Mattion","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.06.073_b0085","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.vaccine.2013.12.007","article-title":"Accuracy of traditional and novel serology tests for predicting cross-protection in foot-and-mouth disease vaccinated cattle","volume":"32","author":"Brito","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.06.073_b0090","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1016\/j.vaccine.2008.01.038","article-title":"High potency vaccines induce protection against heterologous challenge with foot-and-mouth disease virus","volume":"26","author":"Brehm","year":"2008","journal-title":"Vaccine"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X16305503?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X16305503?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,4,27]],"date-time":"2019-04-27T11:15:36Z","timestamp":1556363736000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X16305503"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7]]},"references-count":18,"journal-issue":{"issue":"35","published-print":{"date-parts":[[2016,7]]}},"alternative-id":["S0264410X16305503"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2016.06.073","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2016,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Protection induced by a commercial bivalent vaccine against Foot-and-Mouth Disease 2010 field virus from Ecuador","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2016.06.073","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}